Author pages are created from data sourced from our academic publisher partnerships and public sources.
Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making.
- M. Drummond, Ruth S. Brown, +4 authors M. Barbieri
- Value in health : the journal of the…
- 1 July 2003
OBJECTIVES Despite the growing number of pharmacoeconomic (PE)/health economic (HE) studies, very little is known about their use by decision makers. The objectives of the Task Force were to ensure… Expand
Growth hormone use in transitioning patients--clinician and payer concerns.
- S. Lafranchi, M. Macgillivray, P. Fullerton
- The American journal of managed care
- 1 September 2000
Determining which patients with childhood-onset growth hormone (GH) deficiency will require continuing GH therapy into and/or throughout adulthood raises clinical and economic issues, such as… Expand
ISPOR TASK FORCE ON USE OF PHARMACOECONOMIC / HEALTH ECONOMIC INFORMATION IN HEALTH CARE DECISION-MAKING Draft for Discussion * November 20 , 2001